PMID- 30647803 OWN - NLM STAT- MEDLINE DCOM- 20190604 LR - 20220331 IS - 1875-8630 (Electronic) IS - 0278-0240 (Print) IS - 0278-0240 (Linking) VI - 2018 DP - 2018 TI - Assessment of Seven Clinical Tumor Markers in Diagnosis of Non-Small-Cell Lung Cancer. PG - 9845123 LID - 10.1155/2018/9845123 [doi] LID - 9845123 AB - BACKGROUND: The correlation between tumor markers (TM) and TNM stage of non-small-cell lung cancer (NSCLC) has not been widely reported. METHODS: TM levels (CEA, CA125, CA15-3, CA19-9, CA72-4, CYFRA21-1, and SCC-Ag) in 424 cases of lung adenocarcinoma (LAC), 166 cases of lung squamous cell carcinoma (LSCC), and 103 cases of benign chest disease (BCD) were analyzed before treatment. RESULTS: By Kendall's tau-b correlation analysis, CEA, CA125, CA15-3, CA19-9, CA72-4, CYFRA21-1, and SCC-Ag were correlated with T stage of LAC (r = 0.235, p < 0.05; r = 0.298, p < 0.05; r = 0.254, p < 0.05; r = 0.063, p < 0.05; r = 0.080, p < 0.05; r = 0.268, p < 0.05; and r = 0.080, p < 0.05). CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with N stage of LAC (r = 0.356, p < 0.05; r = 0.415, p < 0.05; r = 0.340, p < 0.05; r = 0.117, p < 0.05; r = 0.175, p < 0.05; and r = 0.351, p < 0.05). CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with M stage of LAC (r = 0.365, p < 0.05; r = 0.353, p < 0.05; r = 0.293, p < 0.05; r = 0.135, p < 0.05; r = 0.169, p < 0.05; and r = 0.312, p < 0.05). CA125, CYFRA21-1, and SCC-Ag were correlated with T stage of LSCC (r = 0.202, p < 0.05; r = 0.233, p < 0.05; and r = 0.099, p < 0.05). CA125 and CYFRA21-1 were correlated with N stage of LSCC (r = 0.178, p < 0.05 and r = 0.284, p < 0.05). CA125, CA15-3, and CYFRA21-1 were correlated with M stage of LSCC (r = 0.214, p < 0.05; r = 0.152, p < 0.05; and r = 0.213, p < 0.05). Combining hazard ratio, AUC, sensitivity, specificity, NPV, and PPV, it was concluded that CEA and CYFRA21-1were the most related TM of LAC. SCC-Ag and CYFRA21-1 were the most related TM of LSCC. CONCLUSIONS: CEA combined with CYFRA21-1 contributed to auxiliary diagnosis of LAC. CYFRA21-1 combined with SCC-Ag contributed to auxiliary diagnosis of LSCC. CEA, CA125, CA15-3, CA19-9, CA72-4, and CYFRA21-1 were correlated with primary tissue and metastasis of LAC. CA125 and CYFRA21-1 were correlated with primary tissue and metastasis of LSCC. FAU - Chen, Zhong-Qing AU - Chen ZQ AD - Department of Clinical Laboratory, Guangxi Medical University Affiliated Tumor Hospital, Nanning, 530021 Guangxi Province, China. FAU - Huang, Ling-Sha AU - Huang LS AUID- ORCID: 0000-0002-5372-7815 AD - Department of Clinical Laboratory, Guangxi Medical University Affiliated Tumor Hospital, Nanning, 530021 Guangxi Province, China. FAU - Zhu, Bo AU - Zhu B AUID- ORCID: 0000-0003-1189-644X AD - Department of Clinical Laboratory, Guangxi Medical University Affiliated Tumor Hospital, Nanning, 530021 Guangxi Province, China. LA - eng PT - Journal Article DEP - 20181211 PL - United States TA - Dis Markers JT - Disease markers JID - 8604127 RN - 0 (Antigens, Neoplasm) RN - 0 (Antigens, Tumor-Associated, Carbohydrate) RN - 0 (Biomarkers, Tumor) RN - 0 (CA-125 Antigen) RN - 0 (CA-72-4 antigen) RN - 0 (Carcinoembryonic Antigen) RN - 0 (Keratin-19) RN - 0 (MUC1 protein, human) RN - 0 (MUC16 protein, human) RN - 0 (Membrane Proteins) RN - 0 (Mucin-1) RN - 0 (antigen CYFRA21.1) RN - 0 (carbohydrate antigen 199, human) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Antigens, Neoplasm/metabolism MH - Antigens, Tumor-Associated, Carbohydrate/metabolism MH - Biomarkers, Tumor/*metabolism MH - CA-125 Antigen/metabolism MH - Carcinoembryonic Antigen/metabolism MH - Carcinoma, Non-Small-Cell Lung/*diagnosis/metabolism MH - Female MH - Humans MH - Keratin-19/metabolism MH - Lung Neoplasms/*diagnosis/metabolism MH - Male MH - Membrane Proteins/metabolism MH - Middle Aged MH - Mucin-1/metabolism MH - Neoplasm Staging MH - Sensitivity and Specificity MH - Young Adult PMC - PMC6311751 EDAT- 2019/01/17 06:00 MHDA- 2019/06/05 06:00 PMCR- 2018/12/11 CRDT- 2019/01/17 06:00 PHST- 2018/07/17 00:00 [received] PHST- 2018/08/12 00:00 [revised] PHST- 2018/09/09 00:00 [accepted] PHST- 2019/01/17 06:00 [entrez] PHST- 2019/01/17 06:00 [pubmed] PHST- 2019/06/05 06:00 [medline] PHST- 2018/12/11 00:00 [pmc-release] AID - 10.1155/2018/9845123 [doi] PST - epublish SO - Dis Markers. 2018 Dec 11;2018:9845123. doi: 10.1155/2018/9845123. eCollection 2018.